- Home
- Publications
- Publication Search
- Publication Details
Title
European perspective for effective cancer drug development
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 11, Issue 8, Pages 492-498
Publisher
Springer Nature
Online
2014-06-17
DOI
10.1038/nrclinonc.2014.98
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment?
- (2013) Susen Burock et al. EUROPEAN JOURNAL OF CANCER
- Phase III Trial of Sunitinib in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Patients With Pretreated Metastatic Breast Cancer
- (2013) John P. Crown et al. JOURNAL OF CLINICAL ONCOLOGY
- Towards a prevention model of health care
- (2013) Alasdair Breckenridge et al. NATURE REVIEWS DRUG DISCOVERY
- Appropriate evidence for adaptive marketing authorization
- (2013) Jean Philippe de Jong et al. NATURE REVIEWS DRUG DISCOVERY
- Priorities for improving drug research, development and regulation
- (2013) Susan R. Forda et al. NATURE REVIEWS DRUG DISCOVERY
- Pilot Studies for Personalized Cancer Medicine: Focusing on the Patient for Treatment Selection
- (2013) L. De Mattos-Arruda et al. ONCOLOGIST
- Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval
- (2012) H-G Eichler et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Drug discovery in pharmaceutical industry: productivity challenges and trends
- (2012) Ish Khanna DRUG DISCOVERY TODAY
- Academia–Industry Partnerships: Are we ready for new models of partnership?
- (2012) Denis Lacombe et al. EUROPEAN JOURNAL OF CANCER
- First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
- (2012) Jonas Bergh et al. JOURNAL OF CLINICAL ONCOLOGY
- Drug development in the light of translational science: shine or shade?
- (2011) Martin Wehling DRUG DISCOVERY TODAY
- Randomized, Placebo-Controlled, Phase III Study of Oxaliplatin, Fluorouracil, and Leucovorin With or Without PTK787/ZK 222584 in Patients With Previously Treated Metastatic Colorectal Adenocarcinoma
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Placebo-Controlled, Phase III Study of First-Line Oxaliplatin-Based Chemotherapy Plus PTK787/ZK 222584, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Metastatic Colorectal Adenocarcinoma
- (2011) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
- (2008) Edward S Kim et al. LANCET
- Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma
- (2008) Hans-Georg Eichler et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now